Cadila Healthcare Bonus Issue
Cadila Healthcare is planning a Bonus Issue. The announcement was made on Saturday, 20 February 2010. The company’s equity capital is Rs 68.25 crore. Face value per share is Rs 5. The current price of Rs 745 discounts the company’s Q3 December 2009 annualized EPS of Rs 36.73, by a PE multiple of 20.28. If approved, this will be a maiden bonus issue from Cadila Healthcare. Cadila Healthcare’s net profit surged 73.5% to Rs 125.32 crore on 25.1% rise in total income to Rs 460.40 crore in Q3 December 2009 over Q3 December 2008.
The company’s operations include pharmaceuticals (human formulations, veterinary formulations and bulk drugs), diagnostics, herbal products, skin care products and over the counter (OTC) products.
*To get the password for buy calls, please subscribe to this blog. You will receive the password in next email to you*If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.
Comments
No comments yet.
Leave a comment